Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Angelo's story about taking part in our kidney cancer trial
How the radiation oncology community saved me - a TROG member's moving story
Meet our new TSC Chair-Elect and members
Trial milestone - NINJA prostate cancer trial completes recruitment.
Facility Alliance Member in Focus: Radiation Oncology Network, Western Sydney Local Health District

EORTC 22996-24002/TROG 01.01 – EPO Head & Neck

Completed
Head & Neck

A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head & Neck Squamous Cell Carcinoma

Primary Sponsor

EORTC

Collaborating Groups

TROG Cancer Research

Prev Post

EORTC/TROG 01.03 – Glioblastoma/Temozolomide – 26981/22981

Next Post

TROG 99.06 – Bladder (Phase II)

Related Post

new TROG Scientific Committee Chair Elect and members
21 July, 2026

New TROG Scientific Committee Chair-Elect and members bring diverse experience

LATEST NEWS: 21 July 2026 The TROG Scientific Committee

RAVES sub-study publication
16 July, 2026

TROG 08.03 RAVES sub-study sheds light on quality of life after post-prostatectomy radiotherapy

LATEST NEWS: 16 July 2026 Secondary analysis of data